In summary, our data suggest a novel and missing link that connects the conventional cell-adhesive function of Dsg2 to tumor-suppressive function in GBC through the regulation of cSrc-mediated signaling pathways that play critical roles in EGFR clearance on the cell membrane, leading to acquired resistance to anti-EGFR therapies (Fig. 8). Here, DSG2 is linked to neoplasm.